Johnson RW, Alvarez-Pasquin MJ, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3(4):109–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuft S. How to manage herpes zoster ophthalmicus. Community Eye Health. 2020;33(108):71–2.

PubMed  PubMed Central  Google Scholar 

Gross GE, Eisert L, Doerr HW, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J Dtsch Dermatol Ges. 2020;18(1):55–78.

PubMed  Google Scholar 

Tsatsos M, Athanasiadis I, Myrou A, Saleh MG, Ziakas N. Herpes zoster ophthalmicus: a devastating disease coming back with vengeance or finding its nemesis? J Ophthalmic Vis Res. 2022;17(1):123–9.

PubMed  PubMed Central  Google Scholar 

Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84.

Article  CAS  PubMed  Google Scholar 

Schmader KE, Levin MJ, Gnann JW Jr., et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin Infect Dis. 2012;54(7):922–8.

Article  PubMed  PubMed Central  Google Scholar 

Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96.

Article  PubMed  Google Scholar 

Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019–32.

Article  CAS  PubMed  Google Scholar 

Xia Y, Zhang X, Zhang L, Fu C. Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: a systematic review and network meta-analysis. Front Immunol. 2022;13:978203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herman L, Levin MJ, Rehm S. Shedding light on shingles: the power of prevention. Am J Med. 2016;129(10):1137.

Article  PubMed  Google Scholar 

Curran D, Callegaro A, Fahrbach K, et al. Meta-regression of herpes zoster incidence worldwide. Infect Dis Ther. 2022;11(1):389–403.

Article  PubMed  Google Scholar 

Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310–6.

Article  CAS  PubMed  Google Scholar 

Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–9.

Article  PubMed  Google Scholar 

Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.

Article  PubMed  PubMed Central  Google Scholar 

Izurieta HS, Wernecke M, Kelman J, et al. Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the medicare population ages 65 years and older. Clin Infect Dis. 2017;64(6):785–93.

Article  PubMed  Google Scholar 

Kong CL, Thompson RR, Porco TC, Kim E, Acharya NR. Incidence rate of herpes zoster ophthalmicus: a retrospective cohort study from 1994 through 2018. Ophthalmology. 2020;127(3):324–30.

Article  PubMed  Google Scholar 

Dmitriev AA, Odden J, Mora-Boellstorff D, et al. Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations. Can J Ophthalmol. 2024;59(3):201–7.

Article  PubMed  Google Scholar 

Opstelten W, Van Essen GA, Schellevis F, Verheij TJM, Moons KGM. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006;16(9):692–5.

Article  PubMed  Google Scholar 

Alicino C, Trucchi C, Paganino C, et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study. Hum Vaccin Immunother. 2017;13(2):399–404.

Article  PubMed  Google Scholar 

Cifuentes-Gonzalez C, Rojas-Carabali W, Fonseca-Mora MA, Mejia-Salgado G, Reyes-Guanes J, de-la-Torre A. Colombian Ocular Infectious Epidemiology Study (COIES): herpes zoster ophthalmicus prevalence and sociodemographic characterization, 2015–2019. Int J Infect Dis. 2022;116:27–33.

Article  PubMed  Google Scholar 

Borkar DS, Tham VM, Esterberg E, et al. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology. 2013;120(3):451–6.

Article  PubMed  Google Scholar 

Schmidt SAJ, Kahlert J, Vestergaard M, Schonheyder HC, Sorensen HT. Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality. BMC Infect Dis. 2016;16:99.

Article  PubMed  PubMed Central  Google Scholar 

Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis. 2020;7(1):ofaa005.

Article  PubMed  PubMed Central  Google Scholar 

Dammacco R, Guerriero S, Alessio G, Dammacco F. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review. Int Ophthalmol. 2022;42(2):689–711.

Article  PubMed  Google Scholar 

Liao TL, Chen YM, Liu HJ, Chen DY. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open. 2017;7(1):e014032.

Article  PubMed  PubMed Central  Google Scholar 

Sharew G, Azage M. Predictors of HIV/AIDS related ocular manifestations among HIV/AIDS patients in Felege Hiwot Referral Hospital, Northwest Ethiopia. J Ophthalmol. 2015;2015:965627.

PubMed  Google Scholar 

Nithyanandam S, Joseph M, Stephen J. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients. Int J STD AIDS. 2013;24(2):106–9.

Article  CAS  PubMed  Google Scholar 

Ormerod LD, Larkin JA, Margo CA, et al. Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS. Clin Infect Dis. 1998;26(1):34–45 (discussion 6–7).

Article  CAS  PubMed  Google Scholar 

Taney L, Shah VA, Shah VA, et al. EyeWiki. Acute retinal necrosis. American Academy of Ophthalmology. https://eyewiki.aao.org/Acute_Retinal_Necrosis. Accessed 5 Mar 2024.

Bhavsar A, Lonnet G, Wang C, et al. Increased risk of herpes zoster in adults ≥50 years old diagnosed with COVID-19 in the United States. Open Forum Infect Dis. 2022;9(5):ofac118.

Article  PubMed  PubMed Central  Google Scholar 

López-Lacort M, Correcher-Martínez E, Muñoz-Quiles C, Díez-Domingo J, Orrico A. Risk of herpes zoster in individuals diagnosed with SARS-CoV2 infection in the Valencia region of Spain: a retrospective cohort population-based study. Abstract P2443 and poster. 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark; 2023.

Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078–90.

Article  CAS  PubMed  Google Scholar 

Gringeri M, Battini V, Cammarata G, et al. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. Expert Rev Vaccines. 2022;21(5):675–84.

Article  CAS  PubMed  Google Scholar 

Wan EYF, Chui CSL, Wang Y, et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health West Pac. 2022;21:100393.

PubMed  PubMed Central  Google Scholar 

Rallis KI, Fausto R, Ting DSJ, Al-Aqaba MA, Said DG, Dua HS. Manifestation of herpetic eye disease after COVID-19 vaccine: a UK case series. Ocul Immunol Inflamm. 2022;30(5):1136–41.